Understanding how Ebola virus affects the immune system

Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

NIH-funded research University of Texas Med Br Galveston · NIH-11105942

This study is looking at how the Ebola virus affects the immune system's ability to fight off the infection, which can sometimes lead to serious problems, and it's for anyone interested in understanding how our bodies respond to this virus.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Texas Med Br Galveston NIH-funded
Lab location1 site (Galveston, United States)
Project IDNIH-11105942 on NIH RePORTER

What this research studies

This research investigates how Ebola virus infection alters immune cell responses at various biological levels, including transcriptional, posttranscriptional, and posttranslational changes. By examining these changes, the research aims to uncover why the immune system sometimes fails to respond effectively, leading to severe complications like immune paralysis and hyperinflammation. The project involves multiple research components that will work together to analyze samples from infected cells and nonhuman primates, ensuring a comprehensive understanding of the immune response to Ebola. Advanced techniques such as massive parallel sequencing and mass spectrometry will be utilized to gather and analyze data.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals who have been exposed to or infected with the Ebola virus, particularly those experiencing severe immune responses.

Not a fit: Patients who have not been exposed to the Ebola virus or those with unrelated health conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for Ebola virus disease by enhancing our understanding of immune dysfunction.

How similar studies have performed: Previous research has shown success in understanding immune responses to viral infections, but this specific approach to Ebola virus is relatively novel.

Where this research is happening

Galveston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.